Candriam S.C.A. Ligand Pharmaceuticals Inc Transaction History

Candriam S.C.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$61.72 - $96.74 $836,059 - $1.31 Million	13,546 New	13,546 $904,000
Q3 2019 Oct 21, 2019	SELL	$86.25 - $120.16 $1.29 Million - $1.8 Million	-15,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $1.93 Million - $4.08 Million	15,000 New	15,000 $2.04 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.